Approximately 18 million Americans – 1 out of every 15 adults – have Obstructive Sleep Apnea, or OSA. Boston Medical Center Otolaryngologist Michael Cohen, MD, in partnership with the Sleep Disorders Center is pleased to announce that Inspire Therapy, a FDA-approved therapy for obstructive sleep apnea, is now available to BMC patients. Aside from one other hospital in the area, BMC is the only place offering this therapy to patients. Listen in as Dr. Cohen discusses symptoms of OSA, and this new groundbreaking therapy to help.
